Back to results
US 2021/0069211 A1Published application
Bioavailable solid state (17- β)-hydroxy-4-androsten-3-one esters
AssigneeLipocine Inc.
InventorsMahesh V. Patel, Nachiappan Chidambaram, Satish Kumar Nachaegari, Srinivasan Venkateshwaran, Joel Frank
Life of this patent
Estimating the term…
Abstract
Disclosed are bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one esters suitable for pharmaceutical uses and administration to mammals in need of (17-β)-Hydroxy-4-Androsten-3-one.
Claims23
A pharmaceutical composition comprising or prepared from a crystalline (17-β)-3-Oxoandrost-4-en-17-yl tridecanoate form having a melting point in the range of 68-75° C. fully or partially dissolved in a lipophilic surfactant.
Dependencies are inferred from the claim text.